Contrasting bioAffinity Technologies (NASDAQ:BIAF) & Affinity Energy and Health (OTCMKTS:ALGXY)

bioAffinity Technologies (NASDAQ:BIAF) and Affinity Energy and Health (OTCMKTS:ALGXY) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, valuation and risk.

Volatility & Risk

bioAffinity Technologies has a beta of 3.64, meaning that its share price is 264% more volatile than the S&P 500. Comparatively, Affinity Energy and Health has a beta of 135.11, meaning that its share price is 13,411% more volatile than the S&P 500.

Insider & Institutional Ownership

1.1% of bioAffinity Technologies shares are owned by institutional investors. 44.3% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for bioAffinity Technologies and Affinity Energy and Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	0	0	0	0	N/A
Affinity Energy and Health	0	0	0	0	N/A

Profitability

This table compares bioAffinity Technologies and Affinity Energy and Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-39,277.73%	-92.37%	-83.91%
Affinity Energy and Health	N/A	N/A	N/A

Earnings and Valuation

This table compares bioAffinity Technologies and Affinity Energy and Health’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	N/A	N/A	-$8.15 million	N/A	N/A
Affinity Energy and Health	$2.05 million	N/A	-$6.08 million	N/A	N/A

Affinity Energy and Health has higher revenue and earnings than bioAffinity Technologies.

Summary

Affinity Energy and Health beats bioAffinity Technologies on 6 of the 8 factors compared between the two stocks.

About bioAffinity Technologies

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

About Affinity Energy and Health

Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.